Can Resistance Enhance Selection of Treatment? (CREST)

This study has been completed.
Sponsor:
Collaborators:
Abbott
Boehringer Ingelheim
GlaxoSmithKline
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Roche Pharma AG
Virco
Diagnostic Technology
Perkin Elmer Inc.
Information provided by:
Kirby Institute
ClinicalTrials.gov Identifier:
NCT00262717
First received: December 6, 2005
Last updated: June 8, 2006
Last verified: June 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2002
  Estimated Primary Completion Date: No date given